Effects of hydroxytyrosol on cardiovascular biomarkers in experimental diabetes mellitus

Juan Antonio López-Villodres,Miriam Abdel-Karim,José Pedro De La Cruz,María Dolores Rodríguez-Pérez,José Julio Reyes,Rocío Guzmán-Moscoso,Guillermo Rodriguez-Gutierrez,Juan Fernández-Bolaños,José Antonio González-Correa
DOI: https://doi.org/10.1016/j.jnutbio.2016.07.015
Abstract:The aim of this study was to assess the influence of hydroxytyrosol (HT) on cardiovascular biomarkers and morphometric parameters of the arterial wall in streptozotocin-diabetic rats. Seven groups of rats (N=10 per group) were studied for 2 months: nondiabetic rats (NDR), diabetic rats treated with saline (DR) and DR treated with HT (0.5, 1, 2.5, 5 and 10 mg kg-1 day-1 p.o.). DR had higher platelet aggregation values, higher thromboxane B2, plasma lipid peroxidation, 3-nitrotyrosine, oxidized LDL (oxLDL), myeloperoxidase, vascular cell adhesion molecule 1 (VCAM-1) and interleukin-1β (IL-1β) concentrations, and lower aortic 6-keto-prostaglandin F1α and nitric oxide production than NDR. Aortic wall area and smooth muscle cell count were also higher in DR than in NDR. HT significantly reduced both oxidative and nitrosative stress, oxLDL concentration, VCAM-1 and inflammatory mediators, platelet aggregation and thromboxane B2 production. Morphometric values in the aortic wall were reduced to values near those in NDR. In conclusion, HT influenced the major biochemical processes leading to diabetic vasculopathy, and reduced cell proliferation in the vascular wall in this experimental model.
What problem does this paper attempt to address?